COPD in Never-Smokers: BOLD Australia Study

References

• WHO Global Health Estimates. The top 10 causes of death. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed July 1, 2021.
   Google Scholar
• Australian Institute of Health and Welfare. Deaths in Australia Australian institute of health and welfare. Available from: https://www.aihw.gov.au/reports/life-expectancy-death/deaths/data. Accessed October 5, 2020.
   Google Scholar
• Toelle BG, Ampon RD, Abramson MJ, et al. Prevalence of chronic obstructive pulmonary disease with breathlessness in Australia: weighted using the 2016 Australian census. Internal Med J. 2021;51(5):784–787. doi:10.1111/imj.15325
   PubMed Web of Science ®Google Scholar
• Australian Bureau of Statistics. Twenty years of population change (feature article); 2019. Available from: https://www.abs.gov.au/ausstats/[email protected]/0/1cd2b1952afc5e7aca257298000f2e76. Accessed July 4, 2021.
   Google Scholar
• Han MK, Postma D, Mannino DM, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176(12):1179–1184. doi:10.1164/rccm.200704-553CC
   PubMed Web of Science ®Google Scholar
• Lisspers K, Larsson K, Janson C, et al. Gender differences among Swedish COPD patients: results from the arctic, a real-world retrospective cohort study. NPJ Prim Care Respir Med. 2019;29(1):1–8. doi:10.1038/s41533-019-0157-3
   PubMedGoogle Scholar
• Yang IA, Brown JL, George J, et al. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update. Med J Aust. 2017;207(10):436–442. doi:10.5694/mja17.00686
   PubMed Web of Science ®Google Scholar
• Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers. Chest. 2011;139(4):752–763. doi:10.1378/chest.10-1253
   PubMed Web of Science ®Google Scholar
• Lee SH, Hwang ED, Lim JE, et al. The risk factors and characteristics of COPD among nonsmokers in Korea: an analysis of KNHANES IV and V. Lung. 2016;194(3):353–361. doi:10.1007/s00408-016-9871-6
   PubMed Web of Science ®Google Scholar
• Hagstad S, Ekerljung L, Lindberg A, Backman H, Rönmark E, Lundbäck B. COPD among non-smokers – report from the Obstructive Lung Disease in Northern Sweden (OLIN) studies. Respir Med. 2012;106(7):980–988. doi:10.1016/j.rmed.2012.03.010
   PubMed Web of Science ®Google Scholar
• Terzikhan N, Verhamme KMC, Hofman A, Stricker BH, Brusselle GG, Lahousse L. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam study. Eur J Epidemiol. 2016;31(8):785–792. doi:10.1007/s10654-016-0132-z
   PubMed Web of Science ®Google Scholar
• Denguezli M, Daldoul H, Harrabi I, et al. COPD in nonsmokers: reports from the Tunisian population-based burden of obstructive lung disease study Behrens T, ed. PLoS One. 2016;11(3):e0151981. doi:10.1371/journal.pone.0151981
   PubMed Web of Science ®Google Scholar
• Lamprecht B, Schirnhofer L, Kaiser B, Buist S, Studnicka M. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med. 2008;102(12):1833–1838. doi:10.1016/j.rmed.2008.07.007
   PubMed Web of Science ®Google Scholar
• Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust. 2013;198(3):144–148. doi:10.5694/mja11.11640
   PubMed Web of Science ®Google Scholar
• Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD. 2005;2(2):277–283. doi:10.1081/COPD-57610
   PubMedGoogle Scholar
• Miller MR. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312
   PubMed Web of Science ®Google Scholar
• Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): Volume 1. Main structure and greater capital city statistical areas; 2016.
   Google Scholar
• GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2021 report. GOLD. 2021;176:532–55.
   Google Scholar
• Textor J, Van Der Zander B, Gilthorpe MS, Liśkiewicz M, Ellison GTH. Robust causal inference using directed acyclic graphs: the R package ‘dagitty. Int J Epidemiol. 2017;dyw341. doi:10.1093/ije/dyw341
   Web of Science ®Google Scholar
• Lederer DJ, Bell SC, Branson RD, et al.; Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann ATS. 2019;16(1):22–28. doi:10.1513/AnnalsATS.201808-564PS
   Google Scholar
• Tan WC, Sin DD, Bourbeau J, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015;70(9):822–829. doi:10.1136/thoraxjnl-2015-206938
   PubMed Web of Science ®Google Scholar
• Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:9691):733–743. doi:10.1016/S0140-6736(09)61303-9
   Google Scholar
• Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022;10(5):497–511. doi:10.1016/S2213-2600(21)00506-3
   PubMed Web of Science ®Google Scholar
• Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest. 2005;128(3):1239–1244. doi:10.1378/chest.128.3.1239
   PubMed Web of Science ®Google Scholar
• Bang KM. Chronic obstructive pulmonary disease in nonsmokers by occupation and exposure: a brief review. Curr Opin Pulm Med. 2015;21(2):149–154. doi:10.1097/MCP.0000000000000135
   PubMed Web of Science ®Google Scholar
• Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(9):1130–1139. doi:10.1164/rccm.201804-0621CI
   PubMed Web of Science ®Google Scholar
• Ho T, Cusack RP, Chaudhary N, Satia I, Kurmi OP. Under- and over-diagnosis of COPD: a global perspective. Breathe. 2019;15(1):24–35. doi:10.1183/20734735.0346-2018
   Web of Science ®Google Scholar
• Petrie K, Toelle BG, Wood-Baker R, et al. Undiagnosed and misdiagnosed chronic obstructive pulmonary disease: data from the BOLD Australia study. COPD. 2021;16:467–475. doi:10.2147/COPD.S287172
   Google Scholar
• Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-2535
   PubMed Web of Science ®Google Scholar
• Gut-Gobert C, Cavaillès A, Dixmier A, et al. Women and COPD: do we need more evidence? Eur Respir Rev. 2019;28(151):180055. doi:10.1183/16000617.0055-2018
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, Soriano JB. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J. 2013;41(6):1252–1256. doi:10.1183/09031936.00118912
   PubMed Web of Science ®Google Scholar
• Bui DS, Lodge CJ, Burgess JA, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. 2018;6(7):535–544. doi:10.1016/S2213-2600(18)30100-0
   PubMed Web of Science ®Google Scholar
• Duan P, Wang Y, Lin R, et al. Impact of early life exposures on COPD in adulthood: a systematic review and meta-analysis. Respirology. 2021;26(12):1131–1151. doi:10.1111/resp.14144
   PubMed Web of Science ®Google Scholar
• Hagstad S, Backman H, Bjerg A, et al. Prevalence and risk factors of COPD among never-smokers in two areas of Sweden - Occupational exposure to gas, dust or fumes is an important risk factor. Respir Med. 2015;109(11):1439–1445. doi:10.1016/j.rmed.2015.09.012
   PubMed Web of Science ®Google Scholar
• Benincasa G, DeMeo DL, Glass K, Silverman EK, Napoli C. Epigenetics and pulmonary diseases in the horizon of precision medicine: a review. Eur Respir J. 2021;57(6):2003406. doi:10.1183/13993003.03406-2020
   PubMed Web of Science ®Google Scholar
• Park HJ, Cho JH, Kim HJ, Park JY, Lee HS, Byun MK. The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality. J Internal Med. 2019;286(5):573–582. doi:10.1111/joim.12949
   Google Scholar
• Sun Y, Milne S, Jaw JE, et al. BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials. Respir Res. 2019;20(1):236. doi:10.1186/s12931-019-1209-5
   PubMed Web of Science ®Google Scholar